Literature DB >> 3034878

Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity.

F A Robey, K Ohura, S Futaki, N Fujii, H Yajima, N Goldman, K D Jones, S Wahl.   

Abstract

We have studied the ability of human C-reactive protein to modulate the immune response in vitro. Whereas native C-reactive protein did not induce phagocytic leukocytes to chemotax or to produce superoxide, treatment of purified C-reactive protein with human neutrophil-derived acid proteases produced substances with potent effects on leukocyte function. Close examination of the primary structure of human C-reactive protein revealed three regions evenly distributed throughout the protein each of which contain peptide sequences closely resembling the amino acid sequence of the immunomodulator peptide tuftsin, Thr-Lys-Pro-Arg. We have synthesized the three peptides which include Thr-Lys-Pro-Leu ([Leu4]tuftsin), Gly-Lys-Pro-Arg ([Gly1]tuftsin), and Thr-Lys-Pro-Gln ([Gln4]tuftsin) and assayed them for biological activity. The three synthetic peptides were found to stimulate phagocytic leukocytes to chemotax, produce superoxide, and induce mononuclear cells to produce interleukin 1 in vitro at concentrations similar to those concentrations required for tuftsin to induce these phenomena. These results support a potentially important role for C-reactive protein as a possible immunomodulator during inflammation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Why measure C reactive protein?

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

2.  Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.

Authors:  C Zouki; M Beauchamp; C Baron; J G Filep
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

3.  Microglia/macrophages promote glioma progression.

Authors:  Haiyan Zhai; Frank L Heppner; Stella E Tsirka
Journal:  Glia       Date:  2010-12-29       Impact factor: 7.452

4.  Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour.

Authors:  B A Fiedel
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

Review 5.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

6.  Degradation of rat C-reactive protein by macrophages.

Authors:  A Nagpurkar; D Hunt; C Y Yang; S Mookerjea
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

7.  Relationship between angiotensinogen, alpha 1-protease inhibitor elastase complex, antithrombin III and C-reactive protein in septic ARDS.

Authors:  U Hilgenfeldt; W Kellermann; G Kienapfel; M Jochum
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

8.  Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models.

Authors:  B P Barna; D A Eppstein; M J Thomassen; J J Nestor; T Ho; S V Medendorp; S D Deodhar
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

9.  Reactivity of anti-human C-reactive protein (CRP) and serum amyloid P component (SAP) monoclonal antibodies with limulin and pentraxins of other species.

Authors:  S C Ying; J J Marchalonis; A T Gewurz; J N Siegel; H Jiang; B E Gewurz; H Gewurz
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

10.  Neutrophil lysosomal degradation of human CRP: CRP-derived peptides modulate neutrophil function.

Authors:  E G Shephard; R Anderson; S M Beer; C E Van Rensburg; F C de Beer
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.